Real-time microbiology laboratory surveillance system to detect abnormal events and emerging infections, Marseille, France

Emerging Infectious Diseases

Volumn 21, Issue 8, 2015, Pages 1302-1310

  Abat, Cédric ^a   Chaudet, Hervé ^b   Colson, Philippe ^a   Rolain, Jean Marc ^a   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b AIX MARSEILLE UNIV   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; METICILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; CITROBACTER KOSERI; CLINICAL LABORATORY; COMPUTER PROGRAM; DISEASE SURVEILLANCE; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROCOCCUS AVIUM; ESCHERICHIA COLI; FRANCE; GROWTH INHIBITION; HUMAN; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; MICROCOCCUS LUTEUS; MORAXELLA CATARRHALIS; MORGANELLA MORGANII; PHENOTYPE; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SALMONELLA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS AGALACTIAE; DECISION SUPPORT SYSTEM; DISEASE NOTIFICATION; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; EPIDEMIOLOGY; LABORATORY; MICROBIOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA; TRENDS;

DECISION MAKING, COMPUTER-ASSISTED; DISEASE NOTIFICATION; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; FRANCE; HUMANS; LABORATORIES; MICROBIOLOGY;

EID: 84937396165     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2108.141419     Document Type: Article

References (26)

1. Raoult D. Les causes de l'émergence des agents infectieux. Responsabilité et Environnement. 2008;51:21-5. http://dx.doi.org/ 10.3917/re.051.0021
2. Raoult D. Molecular, epidemiological, and clinical complexities of predicting patterns of infectious diseases. Front Microbiol. 2011;2:25. http://dx.doi.org/10.3389/fmicb.2011.00025
3. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature. 2004;430:242-9. http://dx.doi.org/10.1038/nature02759
4. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. 2008;451:990-3. http://dx.doi.org/10.1038/nature06536
5. Zeng D, Chen H, Castillo-Chavez C, Thurmond M. Clinical laboratory data for biosurveillance. In: Zeng D., Chen H., Castillo-Chavez C., Lober W.B., Thurmond M., editors. Infectious disease informatics and biosurveillance. New York: Springer; 2011. p. 67-87.
6. Vinnard C, Winston CA, Wileyto EP, Macgregor RR, Bisson GP. Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ. 2010;341:c4451. http://dx.doi.org/10.1136/bmj.c4451
7. van Wessel K. Rodenburg GD, Veenhoven RH, Spanjaard L, van der Ende A, Sanders EA. Nontypeable Haemophilus influenzae invasive disease in The Netherlands: a retrospective surveillance study 2001-2008. Clin Infect Dis. 2011;53:e1-7.
8. Cole MJ, Unemo M, Hoffmann S, Chisholm SA, Ison CA, van de Laar MJ. The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill. 2011;16: 19995.
9. Sala Soler M, Fouillet A, Viso AC, Josseran L, Smith GE, Elliot AJ, et al. Assessment of syndromic surveillance in Europe. Lancet. 2011;378:1833-4. http://dx.doi.org/10.1016/S0140-6736(11)60834-9
10. Severi E, Heinsbroek E, Watson C, Catchpole M. Infectious disease surveillance for the London 2012 Olympic and Paralympic Games. Euro Surveill. 2012;17: 20232.
11. Castillo-Salgado C. Trends and directions of global public health surveillance. Epidemiol Rev. 2010;32:93-109. http://dx.doi.org/ 10.1093/epirev/mxq008
12. van Dijk A, Aramini J, Edge G, Moore KM. Real-time surveillance for respiratory disease outbreaks, Ontario, Canada. Emerg Infect Dis. 2009;15:799-801. http://dx.doi.org/10.3201/eid1505.081174
13. Magiorakos AP, Suetens C, Monnet DL, Gagliotti C, Heuer OE. The rise of carbapenem resistance in Europe: just the tip of the iceberg? Antimicrob Resist Infect Control. 2013;2:6. http://dx.doi.org/10.1186/2047-2994-2-6
14. Colson P, Gouriet F, Badiaga S, Tamalet C, Stein A, Raoult D. Real-time laboratory surveillance of sexually-transmissible infections in Marseille University hospitals reveals rise of gonorrhoea, syphilis and human immunodeficiency virus seroconversions in 2012. Euro Surveill. 2013;18:4.
15. Parola P, Colson P, Dubourg G, Million M, Charrel R, Minodier P, et al. Group A streptococcal infections during the seasonal influenza outbreak 2010/11 in South East England. Euro Surveill. 2011;16:19815.
16. Kempf M, Rolain JM, Azza S, Diene S, Joly-Guillou ML, Dubourg G, et al. Investigation of Acinetobacter baumannii resistance to carbapenems in Marseille hospitals, south of France: a transition from an epidemic to an endemic situation. APMIS. 2013;121:64-71. http://dx.doi.org/10.1111/j.1600-0463.2012.02935.x
17. Seng P, Abat C, Rolain JM, Colson P, Lagier JC, Gouriet F, et al. Identification of rare pathogenic bacteria in a clinical microbiology laboratory: impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2013;51:2182-94. http://dx.doi.org/10.1128/JCM.00492-13
18. Calain P. From the field side of the binoculars: a different view on global public health surveillance. Health Policy Plan. 2007;22:13-20. http://dx.doi.org/10.1093/heapol/czl035
19. Lagier JC, Dubourg G, Cassir N, Fournier PE, Colson P, Richet H, et al. Clostridium difficile 027 emerging outbreak in Marseille, France. Infect Control Hosp Epidemiol. 2013;34:1339-41. http://dx.doi.org/10.1086/673995
20. Kronenberg A, Hilty M, Endimiani A, Muhlemann K. Temporal trends of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in in- and outpatients in Switzerland, 2004 to 2011. Euro Surveill. 2013;18: 20284.
21. Silva JC, Shah SC, Rumoro DP, Bayram JD, Hallock MM, Gibbs GS, et al. Comparing the accuracy of syndrome surveillance systems in detecting influenza-like illness: GUARDIAN vs. RODS vs. electronic medical record reports. Artif Intell Med. 2013;59:169-74. http://dx.doi.org/10.1016/j.artmed.2013.09.001
22. Chaudet H, Anceaux F, Beuscart MC, Pelayo S, Pellegrin L. Facteurs humains et ergonomie en informatique médicale. In: Venot A, Burgun A, Quantin C, editors. Informatique médicale, e-santé-fondements et applications. New York: Springer; 2013. p. 495-520.
23. Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection. 2003;31:208-15.
24. Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care. 2010;14:R113. http://dx.doi.org/10.1186/cc9062
25. Das D, Weiss D, Mostashari F, Treadwell T, McQuiston J, Hutwagner L, et al. Enhanced drop-in syndromic surveillance in New York City following September 11, 2001. J Urban Health. 2003;80(Suppl 1):i76-88.
26. Enki DG, Noufaily A, Garthwaite PH, Andrews NJ, Charlett A, Lane C, et al. Automated biosurveillance data from England and Wales, 1991-2011. Emerg Infect Dis. 2013;19:35-42. http://dx.doi.org/10.3201/eid1901.120493